Citigroup’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100 | Sell |
9
-2
| -18% | -$22 | ﹤0.01% | 4763 |
|
|
2025
Q1 | $151 | Sell |
11
-173
| -94% | -$2.38K | ﹤0.01% | 4634 |
|
|
2024
Q4 | $3.06K | Sell |
184
-10,728
| -98% | -$178K | ﹤0.01% | 4651 |
|
|
2024
Q3 | $206K | Buy |
10,912
+10,240
| +1,524% | +$194K | ﹤0.01% | 3563 |
|
|
2024
Q2 | $9.73K | Sell |
672
-222
| -25% | -$3.22K | ﹤0.01% | 4401 |
|
|
2024
Q1 | $13.8K | Sell |
894
-3,522
| -80% | -$54.5K | ﹤0.01% | 4371 |
|
|
2023
Q4 | $124K | Sell |
4,416
-19,825
| -82% | -$555K | ﹤0.01% | 3373 |
|
|
2023
Q3 | $1.15M | Buy |
24,241
+11,486
| +90% | +$547K | ﹤0.01% | 1808 |
|
|
2023
Q2 | $1.22M | Buy |
12,755
+2,994
| +31% | +$287K | ﹤0.01% | 2094 |
|
|
2023
Q1 | $1.11M | Buy |
9,761
+2,627
| +37% | +$298K | ﹤0.01% | 1924 |
|
|
2022
Q4 | $799K | Sell |
7,134
-2,404
| -25% | -$269K | ﹤0.01% | 2217 |
|
|
2022
Q3 | $1.23M | Buy |
9,538
+9,070
| +1,938% | +$1.16M | ﹤0.01% | 1960 |
|
|
2022
Q2 | $32K | Sell |
468
-2,148
| -82% | -$147K | ﹤0.01% | 4070 |
|
|
2022
Q1 | $373K | Sell |
2,616
-10,707
| -80% | -$1.53M | ﹤0.01% | 3033 |
|
|
2021
Q4 | $2.22M | Sell |
13,323
-2,823
| -17% | -$470K | ﹤0.01% | 1902 |
|
|
2021
Q3 | $2.25M | Buy |
16,146
+6,003
| +59% | +$835K | ﹤0.01% | 1830 |
|
|
2021
Q2 | $4.84M | Buy |
10,143
+119
| +1% | +$56.8K | ﹤0.01% | 1438 |
|
|
2021
Q1 | $4.13M | Buy |
10,024
+9,212
| +1,134% | +$3.79M | ﹤0.01% | 1450 |
|
|
2020
Q4 | $398K | Buy |
812
+305
| +60% | +$149K | ﹤0.01% | 2785 |
|
|
2020
Q3 | $287K | Sell |
507
-2,092
| -80% | -$1.18M | ﹤0.01% | 2575 |
|
|
2020
Q2 | $247K | Buy |
2,599
+1,809
| +229% | +$172K | ﹤0.01% | 2975 |
|
|
2020
Q1 | $56K | Buy |
790
+103
| +15% | +$7.3K | ﹤0.01% | 3708 |
|
|
2019
Q4 | $47K | Buy |
687
+451
| +191% | +$30.9K | ﹤0.01% | 4002 |
|
|
2019
Q3 | $19K | Sell |
236
-162
| -41% | -$13K | ﹤0.01% | 4301 |
|
|
2019
Q2 | $25K | Buy |
398
+41
| +11% | +$2.58K | ﹤0.01% | 4480 |
|
|
2019
Q1 | $49K | Buy |
357
+74
| +26% | +$10.2K | ﹤0.01% | 4033 |
|
|
2018
Q4 | $26K | Sell |
283
-3
| -1% | -$276 | ﹤0.01% | 4304 |
|
|
2018
Q3 | $43K | Buy |
286
+236
| +472% | +$35.5K | ﹤0.01% | 4168 |
|
|
2018
Q2 | $9K | Sell |
50
-5
| -9% | -$900 | ﹤0.01% | 4641 |
|
|
2018
Q1 | $8K | Sell |
55
-4
| -7% | -$582 | ﹤0.01% | 4537 |
|
|
2017
Q4 | $12K | Buy |
59
+2
| +4% | +$407 | ﹤0.01% | 4433 |
|
|
2017
Q3 | $18K | Sell |
57
-3
| -5% | -$947 | ﹤0.01% | 4041 |
|
|
2017
Q2 | $14K | Buy |
60
+10
| +20% | +$2.33K | ﹤0.01% | 4051 |
|
|
2017
Q1 | $11K | Sell |
50
-330
| -87% | -$72.6K | ﹤0.01% | 4262 |
|
|
2016
Q4 | $75K | Sell |
380
-277
| -42% | -$54.7K | ﹤0.01% | 4007 |
|
|
2016
Q3 | $162K | Buy |
657
+256
| +64% | +$63.1K | ﹤0.01% | 3115 |
|
|
2016
Q2 | $233K | Sell |
401
-222
| -36% | -$129K | ﹤0.01% | 2750 |
|
|
2016
Q1 | $331K | Buy |
623
+222
| +55% | +$118K | ﹤0.01% | 3064 |
|
|
2015
Q4 | $281K | Buy |
401
+215
| +116% | +$151K | ﹤0.01% | 2801 |
|
|
2015
Q3 | $110K | Buy |
+186
| New | +$110K | ﹤0.01% | 3124 |
|